Timur Ya. Vakhitov

Timur Ya. Vakhitov

Auto-generated profile, based on publicly available information

Timur Ya. Vakhitov

Institute of Experimental Medicine

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
29 December 2020 in Almanac of Clinical Medicine
Verified
Journal Article
Open access
PDF file
ESE. S. Shcherbakova
E. S. Shcherbakova
TSTatyana Sall
Tatyana Sall
SSStanislav Sitkin
Stanislav Sitkin
TVT. Ya. Vakhitov
T. Ya. Vakhitov
EDE. V. Demyanova
E. V. Demyanova
ТВТ. Я. Вахитов
Т. Я. Вахитов
The review deals with the role of aromatic amino acids and their microbial metabolites in the development and progression of non-alcoholic fatty liver disease (NAFLD). Pathological changes typical for NAFLD, as well as abnormal composition and/or functional activity of gut microbiota, results in abnormal aromatic amino acid metabolism. The authors discuss the potential of these amino acids and their bacterial metabolites to produce both negative and positive impact on the main steps of NAFLD pathophysiology, such as lipogenesis and inflammation, as well as on the liver functions through regulation of the intestinal barrier and microbiota-gut-liver axis signaling. The review gives detailed description of the mechanism of biological activity of tryptophan and its derivatives (indole, tryptamine, indole-lactic, indole-propyonic, indole-acetic acids, and indole-3-aldehyde) through the activation of aryl hydrocarbon receptor (AhR), preventing the development of liver steatosis. Bacteria-produced phenyl-alanine metabolites could promote liver steatosis (phenyl acetic and phenyl lactic acids) or, on the contrary, could reduce liver inflammation and increase insulin sensitivity (phenyl propionic acid). Tyramine, para-cumarate, 4-hydroxyphenylacetic acids, being by-products of bacterial catabolism of tyrosine, can prevent NAFLD, whereas para-cresol and phenol accelerate the progression of NAFLD by damaging the barrier properties of intestinal epithelium. Abnormalities in bacterial catabolism of tyrosine, leading to its excess, stimulate fatty acid synthesis and promote lipid infiltration of the liver. The authors emphasize a close interplay between bacterial metabolism of aromatic amino acids by gut microbiota and the functioning of the human body. They hypothesize that microbial metabolites of aromatic amino acids may represent not only therapeutic targets or non-invasive biomarkers, but also serve as bioactive agents for NAFLD treatment and prevention.

1 January 2021 in Voprosy praktičeskoj pediatrii
Verified
Journal Article
Closed access
TVT.Ya. Vakhitov
T.Ya. Vakhitov
IKI.V. Kudryavtsev
I.V. Kudryavtsev
TST.S. Sall
T.S. Sall
NLN.M. Lazareva
N.M. Lazareva
SKS.V. Kononova
S.V. Kononova
SSS.I. Sitkin
S.I. Sitkin
Studies in recent decades have identified the role of various T-helper cell subsets in the pathogenesis of inflammatory bowel diseases (IBD) and have shown the importance of cytokine-mediated regulation of the immune response in patients with ulcerative colitis (UC) and Crohn’s disease (CD). The imbalance between pro-inflammatory and anti-inflammatory cytokines in IBD prevents resolution of inflammation and leads to chronic course, disease progression and tissue destruction. In the review article, the role of key cytokines that are important in the development and progression of IBD is discussed. Of the pro-inflammatory mediators involved in the pathogenesis of IBD, special attention is currently paid to chemokines – cytokines belonging to chemoattractants. Chemokines are responsible for directed migration and attraction of cells expressing a certain set of receptors to organs, tissues and foci of inflammation. The article provides unique data on the importance of some chemokines in IBD. Cytokines, chemokines and their receptors are considered as potential therapeutic targets in IBD. Cytokine-targeted therapy using antibodies against TNF-α and antibodies to IL-12/IL-23 have already shown high efficiency and safety in randomized clinical trials, as well as in real clinical practice in patients with IBD. The data presented by the authors are important for clarifying the role of immunological processes, including microbiome-dependent ones, in the etiopathogenesis of IBD. Key words: inflammatory bowel disease, ulcerative colitis, Crohn’s disease, T-helper cell subsets, cytokines, chemokines, gut microbiome

1 January 2021 in Voprosy praktičeskoj pediatrii
Verified
Journal Article
Closed access
SKSvetlana Kononova
Svetlana Kononova
TAT.Y A.V Akhitov
T.Y A.V Akhitov
Igor KudryavtsevIgor Kudryavtsev
Igor Kudryavtsev
NAN.M.L Azareva
N.M.L Azareva
TAT.S.S All
T.S.S All
SIS.I.S Itkin
S.I.S Itkin
Objective. The increase in the incidence and prevalence of ulcerative colitis (UC) continues to be a worldwide trend. Both T-helpers and produced cytokines, as well as other cells of the immune system, are involved in the immunopathogenesis of UC. The aim of this study was to explore the immunological status and cytokine profile in patients with UC. Since there are significant gender differences in an immune response in inflammatory bowel disease (IBD), only men were included in this study. Patients and methods. 25 male patients with ulcerative colitis and 26 male healthy controls (HC) without IBD were enrolled in the study. T cell subsets were assessed by multicolor flow cytometry. Analysis of cytokines and chemokines in peripheral blood was performed by multiplex enzyme immunoassay. Results. The percentage of CD3+ T lymphocytes was significantly increased in UC patients compared with HC. In patients with UC, a decrease in the naive cytotoxic T lymphocytes (Tcyt) and central memory (CM) Tcyt was revealed with a significant increase in the CD3+CD8+ highly differentiated Tcyt TEMRA (terminally differentiated CD45RA-positive effector memory T-cells). CM regulatory T cells (Treg) subpopulations showed a significant negative correlation with the severity of UC, reproduced in the CD73+CD39+ Treg and CD73–CD39+ Treg subpopulations. The proportion of T follicular helper 2 cells (Tfh2) in patients with UC was significantly increased compared to НС. Analysis of the cytokine profile showed a significant increase in the concentrations of interleukins IL-5, IL-7, IL-12, IL-10, and chemokines CCL3/MIP-1α, CXCL8/IL-8, CXCL11/I-TAC, and CX3CL1/Fractalkine. Conclusion. New data were obtained on significant changes in peripheral blood T-lymphocytes and cytokine profile in male patients with UC, which turned out to be more characteristic of the Th2 response. Changes in the subpopulation composition of circulating follicular T-helpers in UC were associated with a significant increase in the percentage of Tfh2, which can switch the class of antibodies synthesized by B-cells from IgM to IgG and IgA. In addition, a significant increase in plasma concentrations of the cytokine IL-7 and the chemokine CXCL11/I-TAC was shown in patients with UC. Key words: inflammatory bowel disease, ulcerative colitis, T helper cell subsets, cytokines, chemokines

17 June 2025 in Medical academic journal
Verified
Journal Article
Closed access
PDF file
TSTatyana Sall
Tatyana Sall
Ekaterina A LitvinovaEkaterina A Litvinova
Ekaterina A Litvinova
EAElena Arzhanova
Elena Arzhanova
TKTatyana A. Kashina
Tatyana A. Kashina
IVIrina V. Voronkina
Irina V. Voronkina
ВЯВахитов Тимур Яшэрович
Вахитов Тимур Яшэрович
BACKGROUND: Inflammatory bowel diseases are characterized by inflammation of the intestinal mucosa and increased intestinal barrier permeability. When studying the biological effects of drugs, it is important that experimental models adequately reproduce the key pathogenic factors of the disease. AIM: The work aimed to compare the parameters of intestinal epithelial barrier permeability and inflammatory response in inflammatory bowel disease models: Caco-2 cells stimulated with lipopolysaccharides and mice with a knockout of the mucin 2 gene (Muc2–/–). METHODS: In the in vitro model of inflammatory bowel disease, Caco-2 cells were cultured in the presence of lipopolysaccharide at concentrations ranging from 0.1 to 100.0 μg/mL, and its effects on transepithelial electrical resistance, monolayer permeability, expression of the tight junction genes ZO-1 and Claudin-1 and the pro-inflammatory cytokines IL-8 and TNF-α, as well as IL-8 secretion, were evaluated. In the in vivo model of inflammatory bowel disease, mice with a knockout of the mucin 2 gene (Muc2–/–) were used. Intestinal permeability was determined by plasma fluorescein isothiocyanate-dextran concentration after intragastric administration. Histological analysis of colon samples was performed, with evaluation of TNF-α, IL-1β, and IL-10 gene expression and IL-1β and IL-10 protein levels. RESULTS: In in vitro experiments on Caco-2 cells, lipopolysaccharide at a concentration of 10 μg/mL reduced transepithelial electrical resistance by 57% and increased monolayer permeability to fluorescein isothiocyanate-dextran by 38%. At the same time, it increased IL-8 and TNF-α expression 2.8- and 2.3-fold, decreased ZO-1 and Claudin-1 expression by 54% and 53%, and increased IL-8 secretion 27-fold compared with the control. In vivo, intestinal permeability in Muc2–/– mice was 5.8-fold higher; IL-1β and TNF-α expression was 9.9- and 6.8-fold higher; IL-10 expression in Muc2–/– mice was 71% lower; IL-1β content in the colon was 94% higher, and IL-10 content was 44% lower compared with healthy mice. CONCLUSION: The studied in vitro and in vivo models of inflammatory bowel disease exhibit similar trends in intestinal permeability and inflammatory response parameters. These models adequately reproduce the relevant pathogenic factors and complement each other.

25 January 2026 in Experimental and Clinical Gastroenterology
Verified
Journal Article
Closed access
TVT. Ya. Vakhitov
T. Ya. Vakhitov
SSStanislav Sitkin
Stanislav Sitkin
MSMaria Skalinskaya
Maria Skalinskaya
TET. S. Egorova
T. S. Egorova
TSTatyana Sall
Tatyana Sall
DADaniil Azarov
Daniil Azarov
Ulcerative colitis (UC) is characterized by pronounced dysbiosis of the gut microbiota, with previous studies implicating multiple bacterial taxa in disease pathogenesis. This study investigated the species-level diversity of Blautia in 24 UC patients and 15 healthy controls (HC) using 16S rRNA gene sequencing and MALDI-TOF mass spectrometry for species identification. Results demonstrated a marked 10.9-fold increase in Blautia abundance in UC patients (mean 44.6% vs. 5.26% in HC, p=0.0003), with four species - B. obeum, B. luti, B. faecis, and unidentified Blautia sp. (ID 375)-accounting for >80% of the genus. Notably, B. luti showed 100% prevalence in UC patients versus 79.2% in HC (p=0.0086). This Blautia expansion paradoxically correlated with reduced abundance of protective bacteria, including Faecalibacterium duncaniae, Anaerostipes hadrus, and Dorea longicatena, and was associated with increased disease severity. Although Blautia species are known butyrate producers with anti-inflammatory properties, their overabundance in UC represents functional dysbiosis, in which the microbiota attempts metabolic compensation but fails to effectively deliver short-chain fatty acids in the pathologically altered colonic environment. The concurrent depletion of mucus-layer-associated bacteria indicates compromised intestinal barrier integrity. These findings establish Blautia diversity as a potential marker of dysbiosis for UC severity, opening new diagnostic and therapeutic avenues for disease stratification and targeted interventions aimed at restoring eubiotic composition through selective bacterial modulation.